Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report.
Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report.
复制标题
日本糖尿病学会/日本癌症协会糖尿病与癌症联合委员会的报告,第二份报告。
DOI:
10.1111/cas.12889
复制
发表时间:
2016-03
期刊:
影响因子:
5.7
通讯作者:
Nakagama H
中科院分区:
文献类型:
--
作者:
Goto A;Noto H;Noda M;Ueki K;Kasuga M;Tajima N;Ohashi K;Sakai R;Tsugane S;Hamajima N;Tajima K;Imai K;Nakagama H
The Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer published its first report in July 2013 on the epidemiological assessment of the associations of diabetes with cancer risk/prognosis, the common risk factors for diabetes and cancer, and cancer risk associated with diabetes treatment. The Joint Committee continued its work to assess the role of glycemic control in the development of cancer in patients with diabetes. This review shows that high‐quality evidence examining the association between glycemic control and cancer risk is lacking. In 2014, the Japan Diabetes Society (JDS) and the Japanese Cancer Association (JCA) restarted the JDS/JCA Joint Committee on Diabetes and Cancer, which published the second committee report in Japanese [1]. This is the English version of that report. This article has been jointly published in Diabetology International (doi:10.1007/s13340‐016‐0257‐z) and Cancer Science by the Japan Diabetes Society and the Japanese Cancer Association. Members of the JDS/JCA Joint Committee on Diabetes and Cancer. JDS: Mitsuhiko Noda, Kohjiro Ueki, Masato Kasuga, Naoko Tajima, and Ken Ohashi; Editorial collaborators: Atsushi Goto and Hiroshi Noto; JCA: Ryuichi Sakai, Shoichiro Tsugane, Nobuyuki Hamajima, Kazuo Tajima, Kohzoh Imai, and Hitoshi Nakagama.